Collecting duct carcinoma (CDC) is a very rare subtype of renal cell carcinoma (RCC),
accounting for < 2% of all cases of RCC and associated with a very poor prognosis.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Genitourinary CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Survival in patients with rare subtypes of renal cell carcinoma.BJU Int. 2002; 89: 599-600
- Collecting duct renal cell carcinoma: clinical study of a rare tumor.J Urol. 2002; 167: 71-74
- Management of renal collecting duct carcinoma: a systematic review and the McMaster experience.Curr Oncol. 2013; 20: e223-e232
- Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.Front Oncol. 2015; 5: 67
- Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.J Clin Oncol. 2010; 28: 3167-3175
- Nivolumab versus everolimus in advanced renal-cell carcinoma.N Engl J Med. 2015; 373: 1803-1813
- Non-clear cell renal cell carcinoma, part 2: therapy.Clin Adv Hematol Oncol. 2015; 13: 383-391
- Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target.Proc Natl Acad Sci U S A. 2004; 101: 17174-17179
- PD-L1 expression in nonclear-cell renal cell carcinoma.Ann Oncol. 2014; 25: 2178-2184
Article info
Publication history
Published online: February 23, 2016
Accepted:
February 15,
2016
Received:
February 8,
2016
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
